Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib.
Laura C CoatesAndrew G BushmakinOliver FitzGeraldDafna D GladmanLara FallonJoseph C CappelleriMing-Ann HsuPhilip S HelliwellPublished in: Arthritis research & therapy (2021)
ClinicalTrials.gov, NCT01877668 . Registered on June 12, 2013. ClinicalTrials.gov, NCT01882439 . Registered on June 18, 2013.